Live from the NIH registry
Studies recruiting near Fayetteville right now
Top 25 of 124 recruiting studies, sorted by proximity — each links to its official registry page
Post-Concussion Musculoskeletal Injury Risks
Musculoskeletal Injury
N/A
Observational 148 participants sought
Womack Army Medical Center — Fort Bragg, North Carolina (4.1 mi)
· Sponsor: Walter Reed National Military Medical Center
ERP to Improve Functioning in Veterans With OCD
Obsessive Compulsive Disorder (OCD), Comorbid Post-Traumatic Stress Disorder and OCD
N/A
Interventional 160 participants sought
Fayetteville VA Medical Center, Fayetteville, NC — Fayetteville, North Carolina (6.0 mi)
· Sponsor: VA Office of Research and Development
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
Non-small Cell Lung Cancer
Phase 2
Interventional 318 participants sought
FirstHealth of the Carolinas, Inc. — Pinehurst, North Carolina (28.8 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting
Endometrial Cancer
Phase 3
Interventional 710 participants sought
FirstHealth of the Carolinas, Inc. — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Daiichi Sankyo
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: National Cancer Institute (NCI)
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Pinehurst Medical Clinic, Inc. - East — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Boehringer Ingelheim
Comparative Performance of a Vaginal Yeast Test
Vulvovaginal Candidiasis
N/A
Observational 1,200 participants sought
Womack Army Medical Center — Fort Bragg, North Carolina (4.1 mi)
· Sponsor: Uniformed Services University of the Health Sciences
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Phase 3
Interventional 2,500 participants sought
Anthos Investigative Site 1048 — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Anthos Therapeutics, Inc.
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Akero Therapeutics, Inc
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
Cross Creek Medical Clinic, PA — Fayetteville, North Carolina (6.0 mi)
· Sponsor: pH-D Feminine Health LLC
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 1,800 participants sought
89bio Clinical Study Site — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Hoffmann-La Roche
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Fayetteville, North Carolina (6.0 mi)
· Sponsor: GlaxoSmithKline
MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion
Degenerative Disc Disease, Spine Fusion
N/A
Interventional 100 participants sought
Pinehurst Surgical Clinic — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Kuros Biosurgery AG
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: National Cancer Institute (NCI)
Neurocognitive Ankle Training for Instability to Optimize Neuromusculoskeletal Outcomes (NATION)
Chronic Ankle Instability
N/A
Interventional 180 participants sought
Womack Army Medical Center — Fort Bragg, North Carolina (4.1 mi)
· Sponsor: Womack Army Medical Center
A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
Phase 3
Interventional 40 participants sought
GC2402 Study Site 114 — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Grifols Therapeutics LLC
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma
Phase 2, Phase 3
Interventional 189 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 2
Interventional 128 participants sought
FirstHealth Cancer Center — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Teligene US
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 306 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Proteinuric Kidney Disease
Phase 2
Interventional 74 participants sought
Research Site — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Maze Therapeutics
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Small Cell Lung Cancer
Phase 3
Interventional 531 participants sought
FirstHealth of the Carolinas- Speciality Center /ID# 279857 — Pinehurst, North Carolina (28.8 mi)
· Sponsor: AbbVie
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
Traumatic Brain Injury, Insomnia
N/A
Interventional 360 participants sought
Womack Army Medical Center — Fort Bragg, North Carolina (4.1 mi)
· Sponsor: Johns Hopkins University
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Inflammatory Bowel Diseases, Crohn's Disease
Phase 2
Interventional 385 participants sought
Cross Creek Medical Clinic — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)